Literature DB >> 23698595

Neurodegenerative disorders and metabolic disease.

Germaine Pierre1.   

Abstract

Most genetic causes of neurodegenerative disorders in childhood are due to neurometabolic disease. There are over 200 disorders, including aminoacidopathies, creatine disorders, mitochondrial cytopathies, peroxisomal disorders and lysosomal storage disorders. However, diagnosis can pose a challenge to the clinician when patients present with non-specific problems like epilepsy, developmental delay, autism, dystonia and ataxia. The variety of specialist tests involved can also be daunting. This review aims to give a practical approach to the investigation and diagnosis of neurometabolic disease from the neonatal period to late childhood while prioritising disorders where there are therapeutic options. In particular, patients who have a complex clinical picture of several neurological and non-neurological features should be investigated.

Entities:  

Keywords:  Metabolic; developmental delay; encephalopathy; neurodegenerative; neurometabolic

Mesh:

Year:  2013        PMID: 23698595     DOI: 10.1136/archdischild-2012-302840

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

Review 1.  The Drosophila melanogaster as Genetic Model System to Dissect the Mechanisms of Disease that Lead to Neurodegeneration in Adrenoleukodystrophy.

Authors:  Margret H Bülow; Brendon D Parsons; Francesca Di Cara
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Convergent synaptic and circuit substrates underlying autism genetic risks.

Authors:  Aaron McGee; Guohui Li; Zhongming Lu; Shenfeng Qiu
Journal:  Front Biol (Beijing)       Date:  2014-02-01

Review 3.  Maternal Factors that Induce Epigenetic Changes Contribute to Neurological Disorders in Offspring.

Authors:  Avijit Banik; Deepika Kandilya; Seshadri Ramya; Walter Stünkel; Yap Seng Chong; S Thameem Dheen
Journal:  Genes (Basel)       Date:  2017-05-24       Impact factor: 4.096

4.  Suppression of exaggerated NMDAR activity by memantine treatment ameliorates neurological and behavioral deficits in aminopeptidase P1-deficient mice.

Authors:  Young-Soo Bae; Sang Ho Yoon; Young Sook Kim; Sung Pyo Oh; Woo Seok Song; Jin Hee Cha; Myoung-Hwan Kim
Journal:  Exp Mol Med       Date:  2022-08-03       Impact factor: 12.153

5.  Identification and targeted management of a neurodegenerative disorder caused by biallelic mutations in SLC5A6.

Authors:  Nicholas J Smith; Hamish S Scott; Alicia B Byrne; Peer Arts; Steven W Polyak; Jinghua Feng; Andreas W Schreiber; Karin S Kassahn; Christopher N Hahn; Dylan A Mordaunt; Janice M Fletcher; Jillian Lipsett; Drago Bratkovic; Grant W Booker
Journal:  NPJ Genom Med       Date:  2019-11-14       Impact factor: 8.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.